Editas Medicine, Inc.
EDIT
$2.35
-$0.11-4.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.49% | 5.10% | -22.44% | -51.22% | -54.74% |
| Total Depreciation and Amortization | -9.16% | 86.23% | 15.87% | 6.54% | -4.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.35% | 31.59% | 53.57% | 19.92% | 5.91% |
| Change in Net Operating Assets | -1,005.19% | -235.57% | -31.88% | 621.15% | 316.44% |
| Cash from Operations | 21.42% | 1.18% | -22.31% | -42.34% | -59.09% |
| Capital Expenditure | 93.12% | 88.67% | 48.27% | -48.82% | -87.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.70% | -16.26% | 1,437.47% | 953.36% | 17,204.86% |
| Cash from Investing | -14.48% | -12.61% | 2,859.94% | 803.39% | 4,445.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5,435.38% | 2,456.91% | 786.77% | -98.29% | -99.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -105.20% | -- | -- | -- | -- |
| Cash from Financing | -27.77% | 7,551.46% | 5,881.32% | -53.99% | -52.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.16% | 416.09% | 147.39% | 216.17% | 144.15% |